Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7213546

NC(=O)[C@@H]1CCN(Cc2csc3ccnc(O)c23)C1=O.O=C(O)C(F)(F)F

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
F2 P00734 3/20 0.34
F10 P00742 3/20 0.34
PLAT P00750 3/20 0.34
PLG P00747 2/20 0.34
PROC P04070 2/20 0.34
HRH4 Q9H3N8 3/20 0.32
HRH3 Q9Y5N1 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MET P08581 1/20 0.30
PRSS1 P07477 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7219220 1.00 F2 (0.34) F2F10PLATPLGPROC
Trifluoroacetic Acid SCHEMBL7219132 0.92 KDR (0.35) F2F10PLATPLGPROC
Trifluoroacetic Acid SCHEMBL7219407 0.92 KDR (0.35) F2F10PLATPLGPROC
Trifluoroacetic Acid SCHEMBL7446696 0.92 KDR (0.35) F2F10PLATPLGPROC
Trifluoroacetic Acid SCHEMBL7213548 0.89 HRH4 (0.34) F2F10PLATPLGPROC
Trifluoroacetic Acid SCHEMBL7453206 0.89 HRH4 (0.34) F2F10PLATPLGPROC
Trifluoroacetic Acid SCHEMBL7213615 0.85 L3MBTL1 (0.32) F2F10PLATPLGPROC
SCHEMBL7453196 0.84 F2 (0.30) F2F10PLATPLGPROC
SCHEMBL7213490 0.82 F10 (0.40) F2F10PLATPLGPROC
SCHEMBL7456508 0.82 F10 (0.40) F2F10PLATPLGPROC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602864-B1 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-08-05 US disclosed
EP-0944386-B1 SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMA INC (US) 2002-09-18 EP disclosed
US-6281227-B1 INHIBITORS OF THE ACTIVITY OF FACTOR XA. AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-08-28 US disclosed